These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression. Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336 [TBL] [Abstract][Full Text] [Related]
3. High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients. Kastritis E; Roussou M; Michael M; Gavriatopoulou M; Michalis E; Migkou M; Delimpasi S; Kyrtsonis MC; Gogos D; Liapis K; Charitaki E; Repousis P; Terpos E; Dimopoulos MA; Br J Haematol; 2010 Sep; 150(5):587-91. PubMed ID: 20618328 [TBL] [Abstract][Full Text] [Related]
4. Serum level of angiogenin in breast cancer. Sheen-Chen SM; Eng HL; Chen WJ; Chou FF; Chen HS Anticancer Res; 2000; 20(6C):4769-71. PubMed ID: 11205216 [TBL] [Abstract][Full Text] [Related]
5. Low serum angiogenin concentrations in patients with type 2 diabetes. Siebert J; Reiwer-Gostomska M; Babińska Z; Myśliwska J; Myśliwski A; Skopińska-Rózewska E; Sommer E; Skopiński P Diabetes Care; 2007 Dec; 30(12):3086-7. PubMed ID: 17878246 [No Abstract] [Full Text] [Related]
6. Clinical impact of discordance in serum albumin measurements on myeloma international staging system. Kapoor P; Snozek CL; Colby C; Larson DR; Katzmann JA; Rajkumar SV; Greipp PR J Clin Oncol; 2008 Aug; 26(24):4051-2. PubMed ID: 18711203 [No Abstract] [Full Text] [Related]
7. Can serum angiogenin be used to improve the diagnostic performance in prostate cancer screening? Pina F; Botelho F; Lopes T; Lopes I; Figueiredo G; Portugal R; Ferro A; Cruz F; Barros H; Lunet N Eur J Cancer Prev; 2014 May; 23(3):166-72. PubMed ID: 23921786 [TBL] [Abstract][Full Text] [Related]
8. [Serum angiogenin concentration in nasopharyngeal carcinoma patients and its clinical significance]. Xia B; Yang T; Xian J; Wang J Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jul; 20(14):647-8, 651. PubMed ID: 17017190 [TBL] [Abstract][Full Text] [Related]
9. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma. Tsirakis G; Pappa CA; Kanellou P; Stratinaki MA; Xekalou A; Psarakis FE; Sakellaris G; Alegakis A; Stathopoulos EN; Alexandrakis MG Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032 [TBL] [Abstract][Full Text] [Related]
10. Serum angiogenin levels are elevated in ALS, but not Parkinson's disease. van Es MA; Veldink JH; Schelhaas HJ; Bloem BR; Sodaar P; van Nuenen BF; Verbeek M; van de Warrenburg BP; van den Berg LH J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1439-40. PubMed ID: 24876190 [No Abstract] [Full Text] [Related]
11. Serum miR-29a as a marker of multiple myeloma. Sevcikova S; Kubiczkova L; Sedlarikova L; Slaby O; Hajek R Leuk Lymphoma; 2013 Jan; 54(1):189-91. PubMed ID: 22712836 [No Abstract] [Full Text] [Related]
12. Serum angiogenin levels are decreased in patients with psoriasis. Miyagaki T; Sugaya M; Kamata M; Suga H; Morimura S; Tatsuta A; Uwajima Y; Yamamoto M; Shibata S; Fujita H; Asano Y; Kadono T; Sato S; Tada Y Clin Exp Dermatol; 2012 Oct; 37(7):792-3. PubMed ID: 22439842 [No Abstract] [Full Text] [Related]
13. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Zhao H; Grossman HB; Delclos GL; Hwang LY; Troisi CL; Chamberlain RM; Chenoweth MA; Zhang H; Spitz MR; Wu X Cancer; 2005 Jul; 104(1):30-5. PubMed ID: 15912517 [TBL] [Abstract][Full Text] [Related]
14. Angiogenin, interleukins, and growth-factor levels in serum of patients with ovarian cancer: correlation with angiogenesis. Chopra V; Dinh TV; Hannigan EV Cancer J Sci Am; 1996; 2(5):279-85. PubMed ID: 9166545 [TBL] [Abstract][Full Text] [Related]
15. [Serum interleukin-6 in multiple myeloma: I. Relation to selected laboratory indicators of disease]. Scudla V; Bacovský J; Budíková M; Klímová D; Faltýnek L Vnitr Lek; 1995 Sep; 41(9):593-8. PubMed ID: 7483349 [TBL] [Abstract][Full Text] [Related]
16. Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease. Musolino C; Allegra A; Profita M; Alonci A; Saitta S; Russo S; Bonanno A; Innao V; Gangemi S Br J Haematol; 2013 Mar; 160(5):709-10. PubMed ID: 23205532 [No Abstract] [Full Text] [Related]
17. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases]. Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and quantitative staging and monitoring of multiple myeloma. Analysis of 145 clinical cases]. Di Guglielmo R; Vercelli D; Guidi G Recenti Prog Med; 1979 Apr; 66(4):382-417. PubMed ID: 482726 [No Abstract] [Full Text] [Related]
19. High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma. Fang S; Repo H; Joensuu H; Orpana A; Salven P Eur J Cancer; 2011 Jul; 47(11):1708-16. PubMed ID: 21439815 [TBL] [Abstract][Full Text] [Related]
20. [Serum level of IL-17 in patients with multiple myeloma and its clinical significance]. Zhang XL; Zhang WH; Fan XH; Wei F; Zhang M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):930-2. PubMed ID: 22931657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]